Maura Dickler MDAssociate Attending Physician, Memorial Sloan-Kettering Cancer Center; Assistant Professor of Medicine, Weill Medical College of Cornell University
Dr. Maura N. Dickler received her medical degree from the Pritzker School of Medicine at the University of Chicago in Chicago, Illinois. She completed her internship and residency at the University of Chicago Hospitals, followed by a fellowship in hematology and medical oncology at Memorial Sloan-Kettering Cancer Center in New York. Dr. Dickler is board certified in internal medicine and medical oncology.
Dr. Dickler’s clinical research focuses on developing new therapeutic approaches for the treatment of breast cancer and investigating the impact of these therapies on fertility and sexual health. Her studies involve the investigation of therapies that interfere with estrogen in women who have hormone-receptor−positive breast cancer. In addition, she has studied targeted therapies for other growth-factor−signaling pathways, especially those targeting EGFR, VEGF, PI3K, and HER2. Use of these therapies in combination (eg, antiestrogen plus antiangiogenic therapy) is a focus of her work. Other clinical research involves trials evaluating the effects of breast cancer therapy on ovarian reserve in premenopausal women and the use of intravaginal estrogen and other non-hormonal therapies to ameliorate vaginal dryness in postmenopausal women.
Dr. Dickler is a member of the New York Metropolitan Breast Cancer Group, the American Society of Clinical Oncology (ASCO), and the American College of Physicians/American Society of Internal Medicine, among other professional organizations. She also serves on the National Cancer Institute−sponsored Alliance Breast Committee, the Endocrine-Related Cancer Journal Editorial Board, and has been a prior member of the ASCO Breast Cancer Education Committee.
Dr. Dickler has contributed peer-reviewed articles, review articles, book chapters, and abstracts to the medical literature in her field. She is an ad hoc reviewer for several clinical journals, including The Lancet, The New England Journal of Medicine, the Journal of Clinical Oncology, Clinical Cancer Research, and Breast Cancer Research and Treatment.
Associate Attending Physician
Memorial Sloan-Kettering Cancer Center
Weill Medical College of Cornell University, NY
Pritzker School of Medicine, Chicago, Illinois, MD
Resident, University of Chicago Hospitals, Chicago
Fellow, Memorial Sloan-Kettering Cancer Center, New York
Internal Medicine, Medical Oncology
Breast cancer treatment; targeted therapy (estrogen, VEGF, EGFR/HER1, HER2); antiangiogenesis; effect of treatment on fertility and sexual health